Habich, Annegret http://orcid.org/0000-0002-2267-1206
Oltra, Javier
Schwarz, Christopher G. http://orcid.org/0000-0002-1466-8357
Przybelski, Scott A.
Oppedal, Ketil
Inguanzo, Anna
Blanc, Frédéric
Lemstra, Afina W.
Hort, Jakub
Westman, Eric http://orcid.org/0000-0002-3115-2977
Segura, Barbara http://orcid.org/0000-0002-9673-5479
Junque, Carme
Lowe, Val J.
Boeve, Bradley F. http://orcid.org/0000-0002-4153-8187
Aarsland, Dag http://orcid.org/0000-0001-6314-216X
Dierks, Thomas
Kantarci, Kejal
Ferreira, Daniel http://orcid.org/0000-0001-9522-4338
Article History
Received: 23 November 2023
Accepted: 2 April 2024
First Online: 13 April 2024
Competing interests
: The authors declare the following competing interests: A.H., J.O., C.G.S., S.A.P., K.O., A.I., A.W.L., J.H., E.W., B.S., C.J., and T.D. report no disclosures relevant to the manuscript. F.B. has served as national coordinator and principal investigator for clinical trials sponsored by Biogen, Roche, Axovant and Eisai. V.J.L. consults for Bayer Schering Pharma, Piramal Life Sciences, Life Molecular Imaging, Eisai Inc., AVID Radiopharmaceuticals, and Merck Research and receives research support from GE Healthcare, Siemens Molecular Imaging, AVID Radiopharmaceuticals and the NIH (NIA, NCI). B.F.B. has served as an investigator for clinical trials sponsored by Biogen and Alector. He receives royalties from the publication of a book entitled Behavioral Neurology of Dementia (Cambridge Medicine, 2017), serves on the Scientific Advisory Board of the Tau Consortium, and receives research support from NIH, the Mayo Clinic Dorothy and Harry T. Mangurian Jr. Lewy Body Dementia Program, the Little Family Foundation, and the Ted Turner and Family Foundation LBD Functional Genomics Program. D.A. has received research support and/or honoraria from AstraZeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and served as paid consultant for H. Lundbeck, Eisai and Evonik. K.K. serves on the data safety monitoring board for Takeda Global Research and Development Center, Inc., receives research support from Avid Radiopharmaceuticals and Eli Lilly, and receives funding from NIH and Alzheimer’s Drug Discovery Foundation. D.F. consults for BioArctic and has received honoraria from Esteve.